[Experience using immunocorrecting agents in workers engaged in the manufacture of graphite and asbestos products].
Bezzub
S L
SL
Popova
T B
TB
Alekseeva
O G
OG
D001194:Asbestos / Q000009:adverse effects*; D001991:Bronchitis / Q000209:etiology / Q000276:immunology*; D002244:Carbon / Q000009:adverse effects*; D002617:Chemical Industry; D004338:Drug Combinations / Q000627:therapeutic use; D006108:Graphite / Q000009:adverse effects*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008231:Lymphopenia / Q000188:drug therapy* / Q000209:etiology; D009696:Nucleic Acids / Q000627:therapeutic use; D011009:Pneumoconiosis / Q000209:etiology / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014815:Vitamins / Q000627:therapeutic use*
D004338:Drug Combinations; D009696:Nucleic Acids; C058942:Revit; D014815:Vitamins; D001194:Asbestos; D002244:Carbon; D006108:Graphite; C013683:sodium nucleinate
Opyt primeneniia immunokorrigiruiushchikh sredstv u rabochikh proizvodstv grafitovykh i asbestotekhnicheskikh izdelii.